We recommend using a newer internet browser, such as Google Chrome or Microsoft Edge, to optimize your browsing experience.

Skip to main content

Study ID: ONCO1miRviewmets

- Neoplasms, Unknown Primary
- Completed

Study Title: Cost-effectiveness Study of miRviewג„¢ Mets in Patients With Cancer of Unknown Primary (CUP)

Teva Identifier: ONCO1miRviewmets

ClinicalTrials.gov Identifier: NCT01202786

Study Status: Completed

Trial Condition(s): Neoplasms, Unknown Primary

Study Description: Please refer to ClinicalTrials.gov for a description of the trial

ClinicalTrials.gov study records with inclusion and exclusion criteria

cancer icon for clinical trials

Key Participation Requirements

Gender: Female, Male

Age Range: 18 Years and older

Trial Duration: 05/01/2010 - 04/01/2012

Study Type

Observational